Section | Title | Authors | Address |
---|
|
Genes | ALCAM (Activated Leukocyte Cell Adhesion Molecule) | Yavuz E, Oyken M, Erson Bensan AE | http://atlasgeneticsoncology.org/Genes/ALCAMID616ch3q13.html |
Genes | BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) | De Rienzo A, Testa JR | http://atlasgeneticsoncology.org/Genes/BAP1ID755ch3p21.html |
Genes | BCL2 (B-Cell Leukemia/Lymphoma 2) | Mohamed AN | http://atlasgeneticsoncology.org/Genes/BCL2ID49.html |
Genes | C2orf3 | Takimoto M, Peizhong M | http://atlasgeneticsoncology.org/Genes/C2orf3ID54327ch2p12.html |
Genes | CD2AP (CD2 associated protein) | Panni S | http://atlasgeneticsoncology.org/Genes/CD2APID54896ch6p12.html |
Genes | CDK2 (cyclin dependent kinase 2) | Gjörloff Wingren A, Nyesiga B | http://atlasgeneticsoncology.org/Genes/CDK2ID40031ch12q13.html |
Genes | CEBPE (CCAAT/enhancer binding protein epsilon) | Burmeister T | http://atlasgeneticsoncology.org/Genes/CEBPEID42984ch14q11.html |
Genes | FZD4 (frizzled class receptor 4) | Beghini A, Cassaro A | http://atlasgeneticsoncology.org/Genes/FZD4ID40655ch11q14.html |
Genes | GRHL2 (grainyhead like transcription factor 2) | Kars G, Muyan M | http://atlasgeneticsoncology.org/Genes/GRHL2ID50630ch8q22.html |
Genes | HDAC1 (histone deacetylase 1) | Chrun ES, Modolo F, Daniel FI | http://atlasgeneticsoncology.org/Genes/HDAC1ID40802ch1p35.html |
Genes | IDH2 (isocitrate dehydrogenase 2 (NADP+), mitochondrial) | Huret JL, Dessen P | http://atlasgeneticsoncology.org/Genes/IDH2ID49969ch15q26.html |
Genes | INPP4B (Inositol Polyphosphate-4-Phosphate Type II B) | Kazan HH, Gunduz U | http://atlasgeneticsoncology.org/Genes/INPP4BID43320ch4q31.html |
Genes | MAPK4 (mitogen-activated protein kinase 4) | Mathien S, Meloche S | http://atlasgeneticsoncology.org/Genes/MAPK4ID41293ch18q21.html |
Genes | MAPK6 (mitogen-activated protein kinase 6) | Mathien S, Meloche S | http://atlasgeneticsoncology.org/Genes/MAPK6ID43349ch15q21.html |
Genes | MAZ (MYC Associated Zinc Finger Protein) | Karakaya, B., Muyan, M | http://atlasgeneticsoncology.org/Genes/MAZID41307ch16p11.html |
Genes | MYC (MYC proto-oncogene, bHLH transcription factor) | Mohamed AN | http://atlasgeneticsoncology.org/Genes/MYCID27.html |
Genes | NDC80 (NDC80, kinetochore complex component) | Ferrara M, Degrassi F | http://atlasgeneticsoncology.org/Genes/NDC80ID41095ch18p11.html |
Genes | PCSK1 (proprotein convertase subtilisin/kexin type 1) | Demoures B, Siegfried G, Khatib AM | http://atlasgeneticsoncology.org/Genes/PCSK1ID41671ch5q15.html |
Genes | PGR (progesterone receptor) | Sherbet GV | http://atlasgeneticsoncology.org/Genes/PGRID41700ch11q22.html |
Genes | PIMREG (PICALM interacting mitotic regulator) | Archangelo LF | http://atlasgeneticsoncology.org/Genes/PIMREGID54310ch17p13.html |
Genes | PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha) | Nyesiga B, Gjörloff Wingren A | http://atlasgeneticsoncology.org/Genes/PIP5K1AID47397ch1q21.html |
Genes | SNW1 (SNW domain containing 1) | Olgun, CE; Muyan, M | http://atlasgeneticsoncology.org/Genes/SNW1ID42348ch14q24.html |
Genes | UHMK1 (U2AF homology motif kinase 1) | Arfelli, VC; Archangelo, LF. | http://atlasgeneticsoncology.org/Genes/UHMK1ID41071ch1q23.html |
Genes | WDR48 (WD repeat domain 48) | Olazabal-Herrero A, Peters GJ, Giovannetti El, Antonio Rodriguez J | http://atlasgeneticsoncology.org/Genes/WDR48ID53058ch3p22.html |
Genes | WNT10B (wingless-type MMTV integration site family) | Beghini A, Lazzaroni F | http://atlasgeneticsoncology.org/Genes/WNT10BID42817ch12q13.html |
Genes | YEATS4 (YEATS domain containing 4) | Still IH, Lauffart B | http://atlasgeneticsoncology.org/Genes/YEATS4ID40686ch12q15.html |
Leukemias | +X solely in ALL | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/plusXALLID1799.html |
Leukemias | +X solely in lymphomas | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/plusXID1800.html |
Leukemias | +X solely in myeloid malignancies | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/plusXAMLID1221.html |
Leukemias | Acute lymphoblastic leukemia in Down syndrome | Chisholm KM | http://atlasgeneticsoncology.org/Anomalies/LymphoidLeukDownSyndromeID1784.html |
Leukemias | Acute myeloid leukemia with myelodysplasia related changes | Nagy A, Neubauer A | http://atlasgeneticsoncology.org/Anomalies/AMLwithmyelodysplID2041.html |
Leukemias | Aggressive natural killer leukemia (ANKL) | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/AggressiveNKcellLeukID1690.html |
Leukemias | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Meloni-Ehrig A | http://atlasgeneticsoncology.org/Anomalies/BPDCNID2146.html |
Leukemias | Castleman's disease | Juárez Salcedo LM, Dalia S | http://atlasgeneticsoncology.org/Anomalies/CastlemanID2123.html |
Leukemias | Classical Hodgkin lymphoma type PTLD | Chen DB | http://atlasgeneticsoncology.org/Anomalies/ClassicHogkinPTLDID1786.html |
Leukemias | DLBCL subtype: Extranodal lymphoma | Chen DB | http://atlasgeneticsoncology.org/Anomalies/DLBCLExtranodlymphID1576.html |
Leukemias | Double Hit Lymphoma (DHL) | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/DoubleTripleHitNHLID1613.html |
Leukemias | Early T-cell precursor acute lymphoblastic leukemia | Richebourg S | http://atlasgeneticsoncology.org/Anomalies/EarlyTcellALLID1667.html |
Leukemias | Florid follicular hyperplasia PTLD | Chen DB | http://atlasgeneticsoncology.org/Anomalies/FloridFollPTLDID1788.html |
Leukemias | Follicular lymphomas of germinal center (B- or T-cell) origin | Carbone A, Gloghini A | http://atlasgeneticsoncology.org/Anomalies/FollLymphGerminCentID1781.html |
Leukemias | Germinal center B-cell-like diffuse Large B-cell Lymphoma (GCB) DLBCL | Juárez Salcedo LM, Dalia S | http://atlasgeneticsoncology.org/Anomalies/DLBLGerminCenterID2147.html |
Leukemias | M3/M3v acute myeloid leukemia (AML M3/M3v)
| Lafage M, Viguié F | http://atlasgeneticsoncology.org/Anomalies/M3ANLLID1240.html |
Leukemias | Mantle cell lymphoma | Chen DB | http://atlasgeneticsoncology.org/Anomalies/MantleCellID2062.html |
Leukemias | Mixed phenotype acute leukemia (MPAL) | Weinberg O | http://atlasgeneticsoncology.org/Anomalies/MixedPhenoALID1748.html |
Leukemias | Monomorphic PTLD (B- and T/NK-cell types) | Chen DB | http://atlasgeneticsoncology.org/Anomalies/MonomorphicPTLDID1785.html |
Leukemias | Multiple Myeloma | Ho M, Anderson KC, Bianchi G | http://atlasgeneticsoncology.org/Anomalies/MultipleMyelomaID1776.html |
Leukemias | Myelodysplastic syndrome with excess blasts | Bayerl MG | http://atlasgeneticsoncology.org/Anomalies/MyeloExcessBlastsID1798.html |
Leukemias | Myelodysplastic/myeloproliferative neoplasms | Raess PW | http://atlasgeneticsoncology.org/Anomalies/MyelodysplMyeloprolifID1419.html |
Leukemias | Myeloid proliferations in Down syndrome | Chisholm KM | http://atlasgeneticsoncology.org/Anomalies/MyeloidLeukDownSyndromeID1097.html |
Leukemias | Myeloid/Lymphoid neoplasms with abnormalities of PDGFRA | Lancaster-Shorts K, Chaffin, J, Savage NM | http://atlasgeneticsoncology.org/Anomalies/MyeloLymphoPDGFRAID1744.html |
Leukemias | Myeloid/Lymphoid neoplasms with abnormalities of PDGFRB | Lancaster-Shorts K, Chaffin, J, Savage NM | http://atlasgeneticsoncology.org/Anomalies/MyeloLymphoPDGFRBID1745.html |
Leukemias | Pediatric T-Cell Acute Lymphoblastic Leukemia | Micale Mark A | http://atlasgeneticsoncology.org/Anomalies/PediatrTCellALLID1292.html |
Leukemias | Plasma Cell Neoplasms: an overview | Buon E, Ho M, Bianchi G | http://atlasgeneticsoncology.org/Anomalies/PlasmaCellNeoplasmsID1793.html |
Leukemias | Polymorphic PTLD | Chen DB | http://atlasgeneticsoncology.org/Anomalies/PolymorphicPTLDID1751.html |
Leukemias | Primary DLBCL of the central nervous system (CNS) | Chen DB | http://atlasgeneticsoncology.org/Anomalies/DLBCLPrimCNSID2154.html |
Leukemias | Primary cutaneous DLBCL, leg type | Chen DB | http://atlasgeneticsoncology.org/Anomalies/DLBCLPrimCutanID1245.html |
Leukemias | Subcutaneous panniculitis-like T-cell lymphoma | Toosi S, Feldman AL | http://atlasgeneticsoncology.org/Anomalies/SubcutPanniculTcellLNHID1762.html |
Leukemias | del(18)(p11) | Mitev L, Grachlyova L, Asenova A | http://atlasgeneticsoncology.org/Anomalies/del18p11ID1314.html |
Leukemias | del(1p) solely | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/del1pID1501.html |
Leukemias | del(6q) | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/del6qID1248.html |
Leukemias | del(7)(p11-15) solely | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/del7pID1796.html |
Leukemias | del(X)(p22p22) P2RY8/CRLF2 | Juárez-Velázquez R., MartÍnez-Anaya D., Pérez Vera P | http://atlasgeneticsoncology.org/Anomalies/delXp22PR2Y8-CRLF2ID1599.html |
Leukemias | der(15)t(1;15)(q11-12;p11-13) and der(15)t(1;15)(q21-25;p10-13) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/der15t0115ID1811.html |
Leukemias | der(21)t(1;21)(q11-12;p11-13) and der(21)t(1;21)(q21-32;p11-13) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0121q11_32p11_13ID1478.html |
Leukemias | dic(9;12)(p13;p13) PAX5/ETV6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/dic0912ID1065.html |
Leukemias | dup(1q) in ALL | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/dup1qALLID1049.html |
Leukemias | i(7)(q10) | Mohamed AN | http://atlasgeneticsoncology.org/Anomalies/i7q10ID1077.html |
Leukemias | i(7)(q10) in myeloid malignancies | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/i7q10myeloidID1244.html |
Leukemias | i(8)(q10) in ALL | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/i8q10ALLID2052.html |
Leukemias | i(X)(q10) in male patients | Gindina T | http://atlasgeneticsoncology.org/Anomalies/iXq10MaleID1492.html |
Leukemias | i(Xq10) in female patients | Gindina T | http://atlasgeneticsoncology.org/Anomalies/iXq10FemaleID1493.html |
Leukemias | inv(11)(p15q23) NUP98/KMT2A | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv11p15q23ID1605.html |
Leukemias | r(8) | Ashok V, Sundareshan TS | http://atlasgeneticsoncology.org/Anomalies/r8ID1472.html |
Leukemias | t(10;14)(q24;q11) TLX1/TRD | Gindina T, Beel K | http://atlasgeneticsoncology.org/Anomalies/1014ID1068.html |
Leukemias | t(10;14)(q24;q32) NFKB2/IGH | Nadal N | http://atlasgeneticsoncology.org/Anomalies/t1014q24q32NFKB2IGHID2019.html |
Leukemias | t(11;11)(q14;q23) KMT2A/PICALM | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1111q14q23ID1411.html |
Leukemias | t(11;14)(q11;q32) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t1114q11q32ID1806.html |
Leukemias | t(14;19)(q32;p13) IGH/EPOR | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t1419q32p13ID1681.html |
Leukemias | t(17;20)(q21;q11) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1720q21q11ID1779.html |
Leukemias | t(18;21)(p11;q11) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t1821p11q11ID1791.html |
Leukemias | t(1;17)(q42;q21) IRF2BP2/RARA | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0117p34q21ID1603.html |
Leukemias | t(1;5)(p32;q31) without TAL1 rearrangement | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0105p32q31ID1787.html |
Leukemias | t(1;8)(p11-13;q24) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0108p11q24ID1454.html |
Leukemias | t(1;8)(p21-22;q24) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0108p21q24ID1792.html |
Leukemias | t(2;11)(p21;q24) MIR125B1/? | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0211p21q24MIR125B1ID1812.html |
Leukemias | t(2;17)(q32;q21) NABP1/RARA | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0217q32q21ID1601.html |
Leukemias | t(2;18)(p11;q21)IGK/BCL2 and IGK/KDSR | Mitev L, Grachlyova L, Asenova A | http://atlasgeneticsoncology.org/Anomalies/t0218p11q21IGKBCL2KDSRID1461.html |
Leukemias | t(3;11)(p11;p15) NUP98/POU1F1 | Zhong Y, Piazza M, Shetty S | http://atlasgeneticsoncology.org/Anomalies/t0311p11p15ID1632.html |
Leukemias | t(3;17)(q26;q12-21) TBL1XR1/RARA | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0317q26q21ID1602.html |
Leukemias | t(4;11)(q21;q23) KMT2A/AFF1 | Faramand R, Dalia S | http://atlasgeneticsoncology.org/Anomalies/t0411ID1051.html |
Leukemias | t(4;9)(q21.22;p24) SEC31A/JAK2 | Sanford Biggerstaff JA | http://atlasgeneticsoncology.org/Anomalies/t0409q21p24ID1682.html |
Leukemias | t(5;11)(q33;q13) NUMA1/PDGFRB a novel fusion | Ba I, Eclache V, Clappier E | http://atlasgeneticsoncology.org/Anomalies/t0511q33q13ID1693.html |
Leukemias | t(5;17)(p11;q11) | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/t0517p11q11ID1772.html |
Leukemias | t(5;17)(q35;q21) NPM1/RARA | Zamecnikova A, al Bahar S | http://atlasgeneticsoncology.org/Anomalies/t517ID1081.html |
Leukemias | t(6;11)(q24.1;p15.5) NUP98/CCDC28A | Gindina T | http://atlasgeneticsoncology.org/Anomalies/t0611q24p15ID1395.html |
Leukemias | t(6;11)(q27;q23) KMT2A/AFDN | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0611ID1015.html |
Leukemias | t(7;14)(p13;q11) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0714p13q11ID1803.html |
Leukemias | t(7;14)(p15;q11) TRD/HOXA10 | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0714p15q11ID1435.html |
Leukemias | t(7;14)(p15;q32) | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0714p15q32ID1059.html |
Leukemias | t(7;14)(q34;q11) TRA/TRB | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0714q34q11ID1839.html |
Leukemias | t(7;14)(q34;q11) TRA/TRB | Zamecnikova A | http://atlasgeneticsoncology.org/Anomalies/t0714q34q11ID3284.html |
Leukemias | t(X;11)(q28;p15) NUP98/HMGB3 | Gindina T | http://atlasgeneticsoncology.org/Anomalies/t0X11q28p15ID1588.html |
Leukemias | t(X;14)(p22;q32) or t(Y;14)(p11;q32) IGH/CRLF2 | MartÍnez-Anaya D, Juárez-Velázquez R, Moreno-Lorenzana D, Pérez Vera P | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Bone: Chondroblastoma | Cleven AH, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Bone: Chordoma | Cleven AH, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Bone: Giant cell tumour of bone | Cleven AH, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Kidney: ALK-rearranged renal cell carcinoma | Marino-Enriquez A | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Kidney: Renal Oncocytoma | McIntyre K, Hirsch MS | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Malignant Mesothelioma | De Rienzo A, Testa JR | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Solid Tumors | Soft Tissues: Extraskeletal myxoid chondrosarcoma | Dong F, Jo V | http://atlasgeneticsoncology.org/Anomalies/t0X14p22q32IGHCRLF2ID1769.html |
Cancer-Prones | Down syndrome | Chisholm KM | http://atlasgeneticsoncology.org/Kprones/DownSyndromeID10048.html |
Cancer-Prones | Lynch Syndrome | Ricci MT | http://atlasgeneticsoncology.org/Kprones/HNPCCLynchID10049.html |
Deep Insights | Antibody-Drug Conjugates For the Treatment of Hematological Malignancy | Shah SA | http://atlasgeneticsoncology.org/Deep/AntibodyDrugConjugatesID20147.html |
Deep Insights | LINE-1-encoded Reverse Transcriptase in the genesis and therapy of cancer | Sciamanna I, Serafino A , Spadafora C | http://atlasgeneticsoncology.org/Deep/LINE1inCancerID20146.html |